Journal
JOURNAL OF MATERIALS CHEMISTRY B
Volume 1, Issue 35, Pages 4478-4483Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c3tb20692k
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [21071066, 91027038, 21101079, 21175034]
- MOST [2012BAC01B07, 2012AA06A303, 2012BAD29B04, 2012BAK11B01, 2011BAK10B07, 2011BAK10B01, 2010AA06Z302, 2010DFB3047, 2013ZX08012001, 2012BAK17B10, 2012BAK08B01, 2012YQ090194]
- Jiangsu Province
- MOF
- MOE [NCET-12-0879, BE2011626, 201210036, 201310135, 311002]
Ask authors/readers for more resources
The ability to recognize and quantify the molecular chirality of enantiomers at the nanolevel in biological systems constitutes the basis of many critical areas for specific targeting in drug development and metabolite probing. Plasmonic nanoparticle dimers exhibit circular dichroism effects at visible wavelengths, amplifying the chiral signal of chiral molecules. We demonstrate the self-assembly of plasmonic chiroptical dimers through multibody attractive forces mediated by cysteine, which amplified the plasmonic chirality of enantiomers using enantiomeric cysteines (L and D), and achieved chiral recognition and a quantitative chiroptical sensing platform, with a detection limit of 20 pM level for L-cysteine. The versatility of nanoparticle dimers with customized chiroptical response opens up the avenue for adaptation of the plasmonic chiroptical platform for the drug development and proteomic profiling of metabolites.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available